#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12812	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2435	645.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1560	1560	C	828	C,T	827,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21756	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4003	678.1	0	.	n	.	0	T695C	SNP	695	695	T	1257	1257	C	736	C	736	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21756	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4003	678.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1899	1899	A	907	A	907	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21756	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4003	678.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2533	2533	C	739	C	738	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21756	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4003	678.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2607	2607	A	712	A,C	711,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21756	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4003	678.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3159	3159	C	769	C,G	768,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1788	folP	855	855	100.0	folP.l15.c17.ctg.1	2031	109.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1290	1292	AGC	169;174;172	A;G;C	169;174;172	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4330	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3836	140.7	1	SNP	p	S91F	1	.	.	271	273	TTC	736	738	TTC	158;156;156	T;T;C,A	158;156;155,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4330	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3836	140.7	1	SNP	p	G95N	0	.	.	283	285	GGC	748	750	GGC	152;153;154	G;G;C	152;153;154	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4330	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3836	140.7	1	SNP	p	D95G	1	.	.	283	285	GGC	748	750	GGC	152;153;154	G;G;C	152;153;154	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1710	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1824	116.9	1	SNP	p	G45D	0	.	.	133	135	GGC	672	674	GGC	178;178;178	G;G,T;C	178;177,1;178	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	882	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1540	71.6	0	.	n	.	0	A197.	DEL	197	197	A	875	875	A	167	A	167	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4228	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3386	155.8	1	SNP	p	D86N	0	.	.	256	258	GAC	812	814	GAC	181;182;182	G,A;A,C;C	180,1;181,1;182	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4228	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3386	155.8	1	SNP	p	S87R	1	.	.	259	261	CGT	815	817	CGT	183;184;186	C,G;G;T	182,1;184;186	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4228	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3386	155.8	1	SNP	p	R87I	0	.	.	259	261	CGT	815	817	CGT	183;184;186	C,G;G;T	182,1;184;186	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4228	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3386	155.8	1	SNP	p	R87W	0	.	.	259	261	CGT	815	817	CGT	183;184;186	C,G;G;T	182,1;184;186	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4228	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3386	155.8	1	SNP	p	S88P	0	.	.	262	264	TCC	818	820	TCC	187;189;190	T,A;C,T;C	186,1;188,1;190	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3612	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3171	142.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1824	1826	GGC	187;184;183	G;G;C	187;184;183	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1473	1475	GCA	209;209;211	G,A;C;A,G,C	207,1;209;209,1,1	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1476	1478	ATC	208;206;204	A;T,C,G;C	208;204,1,1;204	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1488	1490	GTG	203;206;206	G,T;T,C,G;G	202,1;204,1,1;206	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1488	1490	GTG	203;206;206	G,T;T,C,G;G	202,1;204,1,1;206	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1992	1994	ACC	183;182;184	A;C;C	183;182;184	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2046	2048	GCG	178;178;178	G,A;C,G;G	177,1;177,1;178	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2046	2048	GCG	178;178;178	G,A;C,G;G	177,1;177,1;178	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2169	2171	GGC	177;179;181	G;G;C	177;179;181	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2178	2180	GGC	176;176;175	G;G;C,T	176;176;174,1	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3324	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2900	142.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2196	2198	CCG	189;192;193	C,T,G;C;G,T,C	187,1,1;192;191,1,1	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4614	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3717	155.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1986	1988	CCG	166;163;163	C;C,T;G,A	166;162,1;162,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1902	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2384	99.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	867	867	C	140	C	140	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	100	94.0	porB1a.l15.c17.ctg.1	172	44.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	123	125	ACG	50;49;46	A;C;G	50;49;46	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	100	94.0	porB1a.l15.c17.ctg.1	172	44.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	165	167	CAA	19;16;15	C;A;A	19;16;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	187	90.91	porB1a.l15.c17.ctg.4	187	36.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	17;23;24	T;T;A	17;23;24	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	187	90.91	porB1a.l15.c17.ctg.4	187	36.1	0	.	p	.	0	Y273R	NONSYN	817	819	TAT	59	61	CGT	53;53;53	C;G;T	53;53;53	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	187	90.91	porB1a.l15.c17.ctg.4	187	36.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	53;54;54	A;G;T	53;54;54	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	187	90.91	porB1a.l15.c17.ctg.4	187	36.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	54;54;54	T;A;C	54;54;54	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	187	90.91	porB1a.l15.c17.ctg.4	187	36.1	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	187	90.91	porB1a.l15.c17.ctg.4	187	36.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	187	90.91	porB1a.l15.c17.ctg.4	187	36.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	1;1;1	G;A;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	246	porB1a	984	187	90.91	porB1a.l15.c17.ctg.4	187	36.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	561	563	GAA	238;235;236	G;A;A	238;235;236	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	849	851	GAT	205;207;204	G;A;T	205;207;204	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	972	974	TCA	205;207;205	T,G;C;A	204,1;207;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1101	1103	GTC	202;203;204	G,T;T;C	201,1;203;204	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1113	1115	TCT	208;207;210	T,C;C;T,G	207,1;207;209,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	0	.	p	.	0	H294R	NONSYN	880	882	CAT	1329	1331	CGT	187;190;190	C;G,C;T	187;189,1;190	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1431	1433	GCA	206;207;207	G;C;A,G	206;207;206,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	1	SNP	p	G120K	1	.	.	358	360	AAG	807	809	AAG	209;206;209	A;A;G	209;206;209	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	1	SNP	p	A121D	1	.	.	361	363	GAC	810	812	GAC	207;207;209	G;A;C	207;207;209	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2506	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1846	167.8	1	SNP	p	D121N	0	.	.	361	363	GAC	810	812	GAC	207;207;209	G;A;C	207;207;209	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8598	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5418	198.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1342	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1639	102.3	1	SNP	p	V57M	1	.	.	169	171	ATG	852	854	ATG	249;249;246	A;T;G	249;249;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
